Bigul

Shareholder Meeting / Postal Ballot-Outcome of AGM

Dear Sirs, Please find enclosed summary of the proceedings as required under Regulation 30, Part-A of Schedule-III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations with respect to 24th Annual General Meeting of the company held on Saturday, 22nd September, 2018 at 3:00 PM at the registered office of the company situated at Plot No. 20, Survey No.52, Rajkot- Gondal National Highway No. 27, Hadamtala, Tal. Kotda Sangani, Dist. Rajkot-360311, Gujarat....
24-09-2018
Bigul

CORPORATE ACTION- FIXES RECORD DATE FOR ANNUAL GENERAL MEETING

The cut-off date for the purpose of e-voting will be on 15th September,2018.
31-08-2018
Bigul

CORPORATE ACTION-FIXES BOOK CLOSURE FOR ANNUAL GENERAL MEETING

The Register of Members and the Share Transfer Books of the Company will remain closed from 16th September, 2018 to 22nd September, 2018 (both days inclusive).
31-08-2018
Bigul

SHAREHOLDER MEETING ON SEPTEMBER 22, 2018

The 24th Annual General Meeting ('AGM') of the 'Parmax Pharma Limited' ('the Company') is scheduled to be held on Saturday, 22nd September, 2018 at 3:00 P.M. at registered office of the company at Plot No. 20, Survey No. 52, Rajkot-Gondal National Highway No. 27, Hadamtala, Rajkot - 360311. The Register of Members and the Share Transfer Books of the Company will...
31-08-2018
Bigul

Results-Financial Results For June 30, 2018

This is to inform you that Board of Directors at the meeting held today. i.e. 14th August, 2018, inter alia transacted the following business: 1 Approved considered and taken on record the unaudited Financial Results for the quarter ended 30th June, 2018 along with Limited Review Report of the Company. 2. The company received primary sanction or loan from HDFC Bank, RCC...
14-08-2018
Bigul

Outcome of Board Meeting

Dear sir, This is to inform you that Board of Directors at the meeting held today, i.e. 14th August, 2018, inter alia transacted the following business: 1. Approved considered and taken on record the Unaudited Financial Results for the quarter ended 30th June, 2018 along with Limited Review Report of the Company....
14-08-2018
Bigul

Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended On 30Th June, 2018

PARMAX PHARMA LTDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2018 ,inter alias, to consider and approve Unaudited Financial Results for the Quarter ended on 30th June, 2018 and to discuss any other matter with the permission of Board.
07-08-2018
Bigul

Shareholding for the Period Ended June 30, 2018

Parmax Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2018. For more details, kindly Click here
12-07-2018
Bigul

Statement Of Investor Complaints For The Quarter Ended June 2018

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Mr. Alkesh R. GosaliaDesignation :- Director
07-07-2018
Bigul

Intimation Under Reg. 39(3) Of SEBI (LODR) Reg., 2015

Pursuant to Regulation 39 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company has received request for issue of duplicate share certificate cum transmission of shares against the certificate reported to be lost/misplaced as per the details provided in the attached file. We request you to kindly take the above information on your record and acknowledge.
03-07-2018
Next Page
Close

Let's Open Free Demat Account